VitaNova Life Sciences reported cash from operations of $0.43M and free cash flow of $0.43M for the quarter ended Apr 2026, down 10.6% year over year. This cash flow statement covers 34 quarters of results from Jul 2017 through Apr 2026, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Jul2017 | Oct2017 | Jul2018 | Oct2018 | Jan2019 | Apr2019 | Jul2019 | Oct2019 | Jan2020 | Apr2020 | Jul2020 | Oct2020 | Jan2021 | Apr2021 | Jul2021 | Oct2021 | Jan2022 | Apr2022 | Jul2022 | Oct2022 | Jan2023 | Apr2023 | Jul2023 | Oct2023 | Jan2024 | Apr2024 | Jul2024 | Oct2024 | Jan2025 | Apr2025 | Jul2025 | Oct2025 | Jan2026 | Apr2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||||||||||||||||||||||
| Net Income | 0.14M | 0.02M | 0.01M | -0.03M | 0.00M | 0.00M | -0.02M | -0.00M | -0.02M | -0.01M | 0.01M | 0.17M | -0.06M | 0.03M | 0.07M | 0.80M | -0.05M | 0.04M | -0.04M | 0.02M | ||||||||||||||
| Share-based CompensationStock Comp. | 0.00M | 750.00 | 750.00 | 500.00 | 0.18M | |||||||||||||||||||||||||||||
| Cash from Discontinued OperationsCash from Discont. Ops | ||||||||||||||||||||||||||||||||||
| Cash from OperationsCash from Ops. | -0.01M | 0.02M | 0.01M | -0.01M | 0.01M | 0.01M | -0.03M | -0.00M | -0.03M | -0.01M | -0.15M | -0.19M | -0.50M | 0.01M | 0.21M | 0.48M | 0.26M | 0.21M | -0.09M | 0.43M | ||||||||||||||
| Change in Working Capital | ||||||||||||||||||||||||||||||||||
| Change in ReceivablesChange Receivables | 0.16M | -0.16M | 0.06M | -0.00M | 1.21M | -0.25M | -0.13M | 0.12M | -0.22M | |||||||||||||||||||||||||
| Change in InventoryChange Inventory | 0.13M | 0.08M | 0.09M | -0.12M | -0.14M | -0.04M | 0.00M | 0.12M | -0.02M | |||||||||||||||||||||||||
| Change in Account PayablesChange Payables | -0.01M | -0.06M | 0.10M | |||||||||||||||||||||||||||||||
| Change in Accured ExpensesChange Accured Exp. | 0.00M | 0.00M | 0.00M | 0.01M | 0.00M | 0.00M | -0.00M | 0.00M | -0.00M | 764.00 | -505.00 | 0.01M | 0.01M | -0.01M | 0.01M | -0.01M | 0.01M | 0.00M | 0.01M | -0.00M | ||||||||||||||
| Change in TaxesChange Taxes | 0.06M | 0.01M | -0.05M | 0.01M | 0.25M | 0.01M | -0.11M | 0.07M | -0.16M | |||||||||||||||||||||||||
| Other Working Capital ChangesOther WC Changes | 0.01M | -588.00 | -0.00M | 0.00M | -0.01M | |||||||||||||||||||||||||||||
| Investing Activities | ||||||||||||||||||||||||||||||||||
| Cash from Investing ActivitiesCash from Investing | ||||||||||||||||||||||||||||||||||
| Financing Activities | ||||||||||||||||||||||||||||||||||
| Other financing activitiesOther financing | 0.02M | |||||||||||||||||||||||||||||||||
| Cash from Financing ActivitiesCash from Financing | 0.01M | 0.01M | 0.00M | 0.02M | 0.01M | 0.96M | -0.02M | 0.05M | 0.07M | -0.03M | -0.10M | |||||||||||||||||||||||
| Change in Capital Stock | ||||||||||||||||||||||||||||||||||
| Net Equity Issued and RepurchasedNet Equity Issued | ||||||||||||||||||||||||||||||||||
| Additional items | ||||||||||||||||||||||||||||||||||
| Change in Cash | 0.03M | 0.01M | -0.01M | 0.01M | 0.01M | -0.02M | -0.00M | -0.01M | 0.81M | -0.22M | -0.45M | 0.08M | 0.18M | 0.38M | 0.26M | 0.21M | -0.09M | 0.43M | ||||||||||||||||
| Beginning Cash Balance | ||||||||||||||||||||||||||||||||||
| Free Cash FlowFCF | -0.01M | 0.02M | 0.01M | -0.01M | 0.01M | 0.01M | -0.03M | -0.00M | -0.03M | -0.01M | -0.15M | -0.19M | -0.50M | 0.01M | 0.21M | 0.48M | 0.26M | 0.21M | -0.09M | 0.43M | ||||||||||||||
| Net Cash FlowNCF | 0.03M | 0.01M | -0.01M | 0.01M | 0.01M | -0.02M | -0.00M | -0.01M | 0.81M | -0.22M | -0.45M | 0.08M | 0.18M | 0.38M | 0.26M | 0.21M | -0.09M | 0.43M |